| n = 43 |
---|---|
Demographics | Â |
 Age years | 54.7 ± 20 |
 Female gender | 42 (50 %) |
 APACHE II score | 22.4 ± 9 |
 SAPS II score | 33.4 ± 22 |
Comorbid conditions | Â |
 Malignancy | 16 (37 %) |
 End-stage liver disease | 9 (21 %) |
 Acute renal failure | 28 (65 %) |
 Diabetes | 10 (23 %) |
Admitting diagnosis | Â |
 Postoperativea | 27 (63 %) |
 Severe sepsis/shock | 19 (44 %) |
 Neurologic failureb | 13 (30 %) |
 GI bleeding/hepatic encephalopathy | 6 (14 %) |
 COPD exacerbation | 4 (9 %) |
 Vasopressors | 23 (53 %) |
 Mean arterial pressure (mmHg) | 79 ± 10.3 |
 pBNP | 2743 (1800, 9253) |
 Serum creatinine (μM/l) | 105 ± 66 |
 Serum Lactate (μM/l) | 2.2 (IQR 1.6) |
 SCVO2 | 65 ± 23.8 |
 Net positive fluid balance | +1145 ml (250, 4527) |
 Hourly urine output (ml/kg/h) | 0.8 (0, 218) |
 Central venous pressure (cmH2O) | 8 ± 1.7 |
Mechanical ventilation | 43 (100Â %) |
 Peak pressure (cmH20) | 29 ± 4.1 |
 PaO2 (mmHg) | 95.4 ± 23.3 |
 FiO2 | 0.41 ± 0.08 |
 PaO2/FiO2 ratio | 235 ± 66 |
 Tidal volume (ml) | 388 ± 78.3 |
Outcome | Â |
 ICU survival | 37 (86 %) |
 28-day survival | 34 (79 %) |